Generic Indocin Sustained-Release is used for treating moderate to severe rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout or certain types of bursitis and tendonitis.
Generic Neoral is used for preventing the rejection of organ transplants (kidney, liver, and heart). This medicine is also used to treat psoriasis and rheumatoid arthritis in certain patients.
Generic Probalan is used in the treatment of chronic gout or gouty arthritis. These conditions are caused by too much uric acid in the blood. The medicine works by removing the extra uric acid from the body.
Generic Relafen is in a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by reducing hormones that cause inflammation and pain in the body. It is used to treat pain or inflammation caused by arthritis.
Cheap arthritis drug effective against killer parasites - New York Daily News
New York Daily NewsCheap arthritis drug effective against killer parasitesNew York Daily NewsA cheap off-patent drug that is commonly used for arthritis could be a wonder treatment for amoebic parasites that infect 50 million people each year, 70000 of them fatally, a study on Sunday said.
May is arthritis awareness month - CattleNetwork.com
May is arthritis awareness monthCattleNetwork.
Dealing with Arthritis: Do You Need Joint Replacement? - GoLocalProv
GoLocalProvDealing with Arthritis: Do You Need Joint Replacement?GoLocalProvOne in three Rhode Islanders over the age of 65 has arthritis.
Timothy Rigdon Endorses Natural Remedies to Arthritis, Anxiety, and Depression - PR Web (press release)
Timothy Rigdon Endorses Natural Remedies to Arthritis, Anxiety, and DepressionPR Web (press release)A new study shows that anxiety and depression are common side effects of arthritis—but pharmaceutical consultant Timothy Rigdon says all three conditions can be treated with natural remedies.
New target to battle rheumatoid arthritis - Science Daily (press release)
Science CodexNew target to battle rheumatoid arthritisScience Daily (press release)ScienceDaily (May 20, 2012) — A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA).
